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Abstract
Introduction Dupuytren’s disease (DD), commonly affect-
ing European men, is generally treated with surgery.
Methods Orthopaedic and plastic surgeons who had been
practicing for >3 and <30 years and operated on ≥5 patients
with DD between September and December 2008 were sur-
veyed in 12 European countries (Czech Republic, Denmark,
Finland, France, Germany, Hungary, Italy, The Netherlands,
Poland, Spain, Sweden and UK). The survey assessed proce-
dures performed, factors influencing choice of procedure, use
of physical therapy and recurrence. Descriptive statistics are
reported.
Results A total of 687 surgeons participated, including 579
orthopaedic and 108 plastic surgeons; 383 (56%) were hand
surgeons. About 37% of surgeons performed percutaneous
needle fasciotomy (PNF), 77% fasciotomy, 95% fasciec-
tomy and 40% dermofasciectomy (DF). Surgeons’ choice
of procedure was influenced by patient preferences, age,
degree of contracture and recurrent disease. The percentage
of surgeons prescribing physical therapy and the mean
(standard deviation [SD]) duration of therapy increased with
procedure complexity: PNF082%, 5.2 (3.9) weeks; fas-
ciotomy094%, 5.3 (3.6); fasciectomy097%, 6.7 (5.1); and
DF099%, 8.5 (6.4). Using survey responses, mean (SD)
estimated recurrence rates decreased and estimated time to
recurrence increased with procedure complexity—PNF044%
(27%), 17 (15) months; fasciotomy030% (24%), 20 (18);
fasciectomy020% (17%), 29 (23); and DF020% (19%), 33
(27).
Conclusions Across Europe, patient and surgical factors
influence the intention to use a surgical procedure. Fasciec-
tomy was the most commonly performed procedure type
and was associated with lower recurrence than PNF or
fasciotomy.
Keywords Dupuytren’sdisease.Cordcontracture.
Fasciectomy.Fasciotomy.Percutaneousneedlefasciotomy.
Dermofasciectomy
Introduction
Dupuytren’s disease (DD) is often treated surgically [1, 2]. In
Europe, the treating surgeons are typically orthopaedic sur-
geons or plastic surgeons, some of whom are specialists in
hand surgery. For example, an analysis of hospital records in
England found that 79% of surgical procedures for palmar
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dic surgeonsand19%wereperformedbyplastic surgeons [3].
A number of different procedures are available for the
surgical treatment of DD, including percutaneous needle fas-
ciotomy (PNF; also known as percutaneous needle aponeur-
otomy or needle fasciotomy), fasciotomy (subcutaneous or
open), fasciectomy (also known as regional palmar fasciec-
tomy or aponeurectomy) and dermofasciectomy (DF) [4].
In a companion article [5] published in this issue, we report
theresultsofapatientchartreview,inwhichsurgeonsreviewed
the charts of patients they treated with a surgical procedure for
DD. This article reports the results of the general experience of
those same surgeons with surgical procedures performed for
DD. Such information may be important when considering and
judging the new treatment strategies available for DD [4].
Differences in surgeons’ responses by country and region are
of interest and will be reported in an upcoming publication.
Methods
The study involved a survey of surgeons who perform
surgical procedures for DD.
Participating surgeons
Orthopaedic and plastic surgeons from 12 European countries
were identified. The countries were selected to take into ac-
count geographic variations between middle and northern
Europe(Table1).Surgeonspecialtieswereselectedtorepresent
a range of surgical practice; participants included specialised
hand surgeons, orthopaedic surgeons and plastic surgeons who
regularly treat patients with DD. Surgeons represented a mix of
public and private practices. Specific surgeons were initially
identified through a variety of means, including telephone
directories, internet sites and directories and hospital contacts.
To be included in the study, surgeons must have been
practicing >3 years and <30 years. Surgeons were required
to have treated at least five patients for DD using a surgical
procedure between September and December 2008. They
were also required to have used at least two of the following
four procedures to treat patients with DD: PNF, fasciotomy,
fasciectomy or DF.
Data collection took place between November 2009 and
January 2010. Surgeons responded to a questionnaire online
or during a face-to-face interview.
Survey
The survey included questions regarding the procedures the
responding surgeon performs for patients with Dupuytren’s
contracture, the surgeon’s level of satisfaction with different
types of procedures, follow-up care typically provided or
recommended following each procedure and the typical recur-
rence patterns following surgery. The survey used the same
definitionsofsurgicalproceduresdescribedinthepatientchart
review found in the companion article [5]. The text of the
surveyisprovidedasElectronicsupplementarymaterialtothis
article.
Statistical analysis
Descriptive statistics were analysed and are reported as
percentages and means with standard deviations (SD).
Results
Demographics of surgeons
A total of 687 surgeons were interviewed, of whom 579
(84%) were orthopaedic surgeons and 108 (16%) were
plastic surgeons (Table 1). Of the participating surgeons,
383 (56%) were hand surgeons, including 339 orthopaedic
surgeons and 44 plastic surgeons. In all countries, some
orthopaedic surgeons self-identified as hand surgeons. In
Germany, The Netherlands and Sweden, some plastic sur-
geons also self-identified as hand surgeons.
Characteristics of physician practice
Respondingsurgeonshadbeeninpracticeforanaverage(SD)
of 15.1 (7.9) years, a figure that did not differ appreciably by
Table 1 Countries surveyed, interview methodology and respondents
by specialty
Surgeon respondents
Country Methodology Total Orthopaedic Plastic Hand
a
Czech Republic Face to face 40 35 5 14
Denmark Online 23 23 – 17
Finland Online 20 20 – 12
France Face to face 91 91 – 75
Germany Face to face
or online
90 65 25 65
Hungary Face to face 50 35 15 27
Italy Face to face 90 80 10 38
The Netherlands Online 42 13 29 26
Poland Face to face 40 40 – 14
Spain Face to face 90 80 10 40
Sweden Online 18 18 – 10
UK Online 93 79 14 45
Total 687 579 108 383
aHand surgeons were a subgroup of orthopaedic and plastic surgeons
26 Eur Orthop Traumatol (2012) 3:25–30specialty. Of the 687 surgeons, 56% practiced only in the
hospital. The remaining surgeons had mixed practices; 35%
of all surgeons had a mixed practice but practiced at least half
the time in the hospital, and 10% had a mixed practice but
spent the majority of time in the office. Of plastic surgeons,
47% had a mixed practice, a higher rate than that of orthopae-
dic (33%) or hand (34%) surgeons.
Overall, surgeons estimated they saw an average (SD) of
1,612 (1,507) patients in consultation in 2008. Each
responding surgeon treated an estimated average (SD) of
17.5 (19.7) patients with Dupuytren’s contracture using a
surgical procedure in 2008. Orthopaedic surgeons treated an
average of 16.4 (18.6) patients; plastic surgeons treated 23.3
(24.3) and hand surgeons treated 20.6 (22.9).
Procedures performed
In a 12-month period, 255 (37%) of the 687 surgeons
performed PNF for patients with DD with finger contracture,
530 (77%) performed fasciotomy, 651 (95%) performed
fasciectomy and 276 (40%) performed DF (Fig. 1). These
proportionsweresimilaracrosssurgicalspecialties,butplastic
surgeons were more likely than orthopaedic surgeons to per-
form DF.
Factors influencing choice of procedure type are shown
in Table 2. Surgeons’ decisions to use less aggressive pro-
cedures (PNF and fasciotomy) were influenced most strongly
by older patient age, patient lifestyle factors and preferences
and less severe contracture. Decisions to use more aggressive
procedures (fasciectomy and DF) were influenced by more
severe contracture, recurrent disease and the speed of disease
progression over time.
Among surgeons who performed each procedure,
more than 65% had patients on a waiting list for each
procedure type. The highest proportion was for fasciec-
tomy; 82% of surgeons performing fasciectomy had a
waiting list for the procedure. The mean estimated wait-
ing time for all procedures was between 7 and 10 weeks,
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Fig. 1 Percentage of surgeons performing each type of procedure in the past 12 months by specialty
Table 2 Factors influencing surgeon’s intention
a to use each surgical procedure
Percutaneous needle fasciotomy Fasciotomy Fasciectomy Dermofasciectomy
Aged >70 years Aged >70 years PIP flexion >45° Patient presenting with
recurrence
MCP flexion <20° Patient’s job/way of life requires
manual dexterity
MCP flexion >45° PIP flexion >45°
Patient request based on aesthetic
reasons
Patient request based on impairment
of activities of daily living
Patient presenting with
recurrence
MCP flexion >45°
Patient comorbidities or risk factors High expectations of success
following surgical procedure
Speed of progression of disease
over time
Speed of progression of disease
over time
Patient request based on impairment
of activities of daily living
MCP flexion >45° High expectations of success
following surgical procedure
High expectations of success
following surgical procedure
PIP flexion <20° Family history of DD Patient’s job/way of life requires
manual dexterity
Family history of DD
DD Dupuytren’s disease, MCP metacarpophalangeal, PIP proximal interphalangeal
aFactors influencing intention to use a procedure were rated from 1 (“strongly decreases”)t o7( “strongly increases”) intention to use each
procedure type; factors are presented in decreasing order of importance
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more invasive procedures.
Satisfaction with procedures
On a scale of 1 (totally dissatisfied) to 7 (very satisfied),
surgeons’ mean (SD) overall level of satisfaction was 5.1
(1.3) for PNF, 5.2 (1.2) for fasciotomy, 5.7 (1.0) for fasciec-
tomy and 5.1 (1.1) for DF. Factors influencing surgeon
satisfaction are shown in Table 3. Surgeons were satisfied
with the low patient burden, few complications and short
time to recovery associated with PNF, and they were satis-
fied with the high patient satisfaction and restoration of
finger functionality associated with fasciotomy. However,
they were dissatisfied with the high likelihood of recurrence
and short time to recurrence associated with these less
aggressive procedures. Surgeons were satisfied with resto-
ration of finger functionality associated with fasciectomy
and DF but were dissatisfied with the high patient burden
associated with both procedures as well as the frequent
complications and long time to recovery associated with DF.
On a scale of 1 to 7, surgeons reported their patients’
mean (SD) level of satisfaction as 5.3 (1.2) for PNF, 5.3
(1.1) for fasciotomy, 5.6 (1.0) for fasciectomy and 5.0 (1.1)
for DF.
Follow-up care
Surgeons estimated that 82% of their patients received
physical therapy for the hand (including the application of
a dynamic splint) following their first PNF procedure and
that the mean (SD) duration of physical therapy (including
use of dynamic splint) was 5.2 (3.9) weeks. Of the other
procedures, 94% of patients receiving fasciotomy had
physical therapy for a mean (SD) of 5.3 (3.6) weeks, 97%
of patients receiving fasciectomy had therapy for a mean of
6.7 (5.1) weeks and 99% of patients receiving DF had
therapy for a mean of 8.5 (6.4) weeks. The patients of hand
surgeons were slightly less likely to receive physical therapy
after PNF or fasciotomy compared with patients of nonhand
surgeons (PNF, 80% vs 87%; fasciotomy, 93% vs 96%). The
proportion of patients receiving physical therapy after fas-
ciectomy or DF was similar for hand and nonhand surgeons.
Most surgeons recommended that patients spend some
time away from work following their surgery. The mean
(SD) time surgeons recommended patients spend out of
work was 2.9 (2.5) weeks following the first PNF procedure,
4.6 (2.7) weeks following fasciotomy, 5.5 (2.7) weeks
following fasciectomy and 6.3 (3.2) weeks following DF.
Orthopaedic surgeons recommended slightly more time
out of work following each procedure type than plastic
surgeons, and nonhand surgeons recommended slightly
more time off than hand surgeons. Also, surgeons recom-
mended approximately 1 week more time out of work
following a reintervention procedure (compared with an
initial procedure).
Recurrence
When asked to estimate the percentage of patients who
experienced recurrence of flexion in the finger that was
operated, surgeons reported higher rates of recurrence and
shorter time to recurrence for less aggressive procedures
compared with more aggressive procedures (Fig. 2). The
mean (SD) estimated recurrence rates were 44% (27%) fol-
lowing PNF, 30% (24%) following fasciotomy, 20% (17%)
following fasciectomy and 20% (19%) following DF. The
mean (SD) estimated time to recurrence was 17 (15) months
following PNF, 20 (18) months following fasciotomy, 29
Table 3 Factors influencing surgeon’s satisfaction with each surgical procedure
Procedure
a Most satisfied with Least satisfied with
Percutaneous needle fasciotomy Low patient burden High likelihood of recurrence
Few complications Short time to recurrence
Short time to recovery
High patient satisfaction
Fasciotomy High patient satisfaction High likelihood of recurrence
Restoration of finger functionality Short time to recurrence
Fasciectomy Restoration of finger functionality High patient burden
High patient satisfaction
Long time to recurrence
Dermofasciectomy Restoration of finger functionality High patient burden
Frequent complications
Long time to recovery
aSatisfaction with each factor was rated from 1 (“not satisfied”)t o7( “very satisfied”) for each procedure type; findings are presented qualitatively
28 Eur Orthop Traumatol (2012) 3:25–30(23) months following fasciectomy and 33 (27) months
following DF.
Discussion
To our knowledge, this is the only survey to date that
collected, quantified and described the experiences of a
large number of surgeons in the management of DD in
Europe. The diverse training (orthopaedic and plastic sur-
geons, more than half qualified hand surgeons) and varied
practicesettings(hospital-based and office-based) ofsurgeons
who participated in this study reflectsa broad range of disease
severity and procedures performed for DD in Europe.
In this study across Europe, fasciectomy was the sur-
geons’ procedure of choice for Dupuytren’s contracture,
especially for patients with more advanced disease and
when a more effective treatment with less likelihood of
recurrence was desired. This finding is similar to that
reported in the literature [3, 6]. Surgeons were more satisfied
with the results of fasciectomy compared with other proce-
dure types, and they reported that their patients were also
more satisfied with fasciectomy.
Surgeons responding to this survey believed their patients
who received fasciectomy and DF had lower recurrence
rates and longer time to recurrence compared with patients
receiving less invasive procedures, a finding that is not
surprising. The rate of recurrence after fasciectomy estimated
by surgeons in this study (20%) is lower than that reported in
the literature (39%) [1]. This may, in part, reflect the limita-
tions of surgeons’ recall and ability to track the progress of
their patients in the years after surgery as well as the varying
definitions of recurrence [2].
In some countries fasciectomy, with and without local
flaps and Z-plasty, is the dominant procedure for DD. Fre-
quency of different procedures by country may depend on
the Tubiana stage of DD most commonly seen in and the
surgical traditions of that country. Differences by country in
the data collected for this study will be presented in a later
publication.
The findings of this study demonstrate that patient factors
play a role in the type of surgery recommended by surgeons.
Surgeons prefer less invasive procedures for older patients
and those with more comorbidities (Table 2). Surgeons also
recognize the lower patient burden and lower rate of com-
plications associated with less invasive procedures (Table 3).
These issues are of particular importance in the DD patient
population, which includes many older patients with com-
plicated concomitant diseases and possibly less demand
for full hand function. Diabetes often co-occurs in patients
with DD [7]; this condition poses challenges to surgical
treatment, including a possible higher risk of complications
and delayed recovery. Even patients with impaired glucose
tolerance have a higher frequency of DD; therefore, the
incidence of DD can be expected to increase in the future
as the global burden of diabetes increases [7].
It has been demonstrated that hand therapy after surgery
results in significant improvement in total digital extension
[8]. In this study, surgeons recommended physical therapy
and dynamic splinting, extending for several weeks, for the
majority of patients receiving surgery, with hand surgeons
slightly less likely than nonhand surgeons to recommend
physical therapy after PNF or fasciotomy. A limitation of
this study is that duration of therapy and of splinting was not
assessed independently. As stated above, surgeons reported
that they recommended that patients spend several weeks
out of work after most procedures. Time out of work was
longer for reintervention procedures, which is not unexpect-
ed as cases involving recurrence often require more compli-
cated surgical procedures (e.g., local flaps and split skin).
The findings regarding time in physical therapy and time
out of work illustrate both the direct (surgery, physical thera-
py) and indirect (time out of work) costs associated with the
treatment of DD. Indirect costs, including time out of work,
have been found to constitute the majority of the total costs of
treatment for DD and other hand injuries [9, 10]. In this study,
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Error bars indicate standard deviations around estimates.
Fig. 2 Potential for recurrence:
surgeon’s report of the
proportion of patients with
recurrence and mean time to
recurrence in the same finger
following the procedure
Eur Orthop Traumatol (2012) 3:25–30 29surgeonsrecommendedalmost3weeksoutofworkfollowing
PNF and approximately 6 weeks out of work following
fasciectomy and DF. In collaboration with the patient, the
surgeon should consider indirect costs when choosing the
surgical procedure to be performed. Because indirect costs
are currently a substantial part of the total health care costs
associated with DD, it will be of great interest to see if new
treatment strategies reduce the indirect costs of treatment.
The findings of this study will provide a valuable point
of reference when new treatment strategies for DD are intro-
duced. For example, surgeons’ preference to use less invasive
techniques in older patients may be related to a higher accept-
abilityoftheriskofrecurrenceinthesepatientswhenweighed
against patient burden and time to recovery. These concerns
may become less salient if new treatments result in reduced
patientburdenand shortened timetorecovery.Thefindingsof
thisstudymayalsoinformdecisionsregardingthedistribution
of additional research resources to the treatment of DD.
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